|
 |
Anti-TumorThis page contains recent news articles, when available, and an overview of Anti-Tumor but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Because STAT3 is known to be up-regulated in tumor microenvironments, and STAT3-driven gene expression triggers global immune suppression of anti-tumor ... CNNMoney.com (press release) Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In ... - Oct 29, 2009 ...arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. ... Science Daily (press release) New Study in Clinical Cancer Research Shows Therapeutic Promise of Peregrine's ... - Nov 10, 2009 ..."The potent anti-tumor effects observed in this study, which used an extremely challenging preclinical model of brain cancer, are very impressive. ... CNNMoney.com (press release) Attacking Cancer With Specific Anti-Tumor Pathways - Oct 19, 2009 The data presented at the AACR showed that Kevetrin was less cytotoxic than paclitaxel, cisplatin and 5FU while having more potent anti-tumor activity in ... Reuters TRIN Pharma Starts Phase I Clinical Trial Of TRIN 2755 In Solid - Nov 12, 2009 The research is focused on innovative compounds with proprietary molecular structure, high selectivity and potent anti-tumor activity. ... Pharmaceutical Online (press release) www.standoutstocks.com: Stocks That Stand Out For Nov. 13th, 2009 Are HRRN ... - Nov 13, 2009 The Anti-tumor Activity of SCV-07 Is Attributable in Part to an Inhibitory Effect on STAT3 Driven Responses Additional data on SCV-07 will be presented in a ... Trading Markets (press release) Insulin-like growth factor binding protein-3 has dual effects on ... - Nov 10, 2009 However, the molecular mechanism through which imatinib exerts its anti-tumor effects is not clear. Previously, we found up-regulation of insulin-like ... 7thSpace Interactive (press release) Pharmacyclics Announces Poster Presentations and Clinical Update at the 51st ... - Nov 12, 2009 ...potent preclinical anti-tumor activity in lymphoma cell lines and models and has previously demonstrated safety and clinical benefit in solid cancers. ... CNNMoney.com (press release) Acceleron Pharma Initiates First-in-Human Study of ACE-041, a Novel ... - Nov 4, 2009 The Phase 1 trial is a multiple-dose, dose-escalating study designed to assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor ... Reuters Spectrum Pharmaceuticals and Nippon Kayaku Enter Collaboration Agreement for ... - Nov 10, 2009 Phase 2 data has confirmed anti-tumor activity in patients with multiple, recurrent non-muscle invasive bladder cancer, as evidenced by 31 of 46 patients ... WELT ONLINE Axelar AB Presents the New Anticancer Agent AXL1717 at The AACR-NCI-EORTC ... - Nov 13, 2009 Pre-clinical data on AXL1717 have shown an extraordinary anti-tumor efficacy in animal models, including complete regression of a wide range of human ... PR Newswire (press release) UPDATE 1-Qiagen beats estimates, tweaks outlook on test sales - Nov 9, 2009 DE) anti-tumor drug Erbitux or from Amgen's (AMGN.O) Vectibix. In the United States, Qiagen is the exclusive supplier of tests needed before Vectibix and ... Reuters Poniard Pharmaceuticals to Present Updated Clinical Data from Phase 2 Trial of ... - Nov 10, 2009 Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors. In addition to the Phase 1 cardiac safety assessment and the Phase 2 trial in ... CNNMoney.com (press release) 'Holy Grail' Of Cancer Therapy: Researchers Find Way To Protect Healthy Cells ... - Oct 21, 2009 Or, suppression of injury to vascular cells might improve blood flow to allow naturally occurring anti-tumor immunity to reach cancer cells more easily. ... Science Daily (press release) YM BIOSCIENCES REPORTS POSITIVE NIMOTUZUMAB FOUR-YEAR SURVIVAL DATA PRESENTED ... - Nov 2, 2009 Nimotuzumab's anti-tumor activity has led to its approval for marketing in 23 countries. In more than 5000 patients reported as having been treated with ... Reuters Tokai Pushes Edge With Three-Pronged Attack on Prostate Cancer - Nov 10, 2009 The company is starting its first clinical trial in 50 patients to test the safety of—and look for some early signs of anti-tumor activity in— a once-daily ... Xconomy EpiCept Corporation Reports Third Quarter Results, Provides Business Update - Nov 9, 2009 Crinobulin (EPC2407) - a vascular disruption agent that has demonstrated potent anti-tumor activity in both preclinical and early clinical studies. ... WELT ONLINE Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co ... - Oct 27, 2009 The interim results showed that MDV3100 was associated with anti-tumor activity in patients who had become resistant to bicalutamide or other standard ... Reuters Immunotherapy Demonstrates Long-Term Success in Treating Lymphoma - Oct 30, 2009 ...count was still low and was not quickly regenerating, allowing the infused cells to more quickly multiply and mediate anti-viral and anti-tumor effects. ... Reuters Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate ... - Nov 9, 2009 IntroductionImmunosuppressants, including anti-tumor necrosis factor (TNF)alpha antibodies, have remarkable effects in rheumatoid arthritis (RA); however, ... 7thSpace Interactive (press release) B7-H4 gene polymorphisms are associated with sporadic breast cancer in a ... - Nov 10, 2009 B7-H4 is expressed in tumor tissues at a higher level than in normal tissues, and has a potential effect to protect tumors from anti-tumor immune responses. ... 7thSpace Interactive (press release) Micromet terminates agreement with MedImmune for MT103 (MEDI-538) - Nov 9, 2009 Both companies successfully tested them for anti-tumor activity in preclinical studies. The preclinical milestone triggered an undisclosed proof-of-concept ... Trading Markets (press release) Spectrum inks $151M Asian pact; Dynavax strikes deal to acquire Symphony Dynamo; - Nov 10, 2009 Story > Xconomy outlines the clinical development plans of Tokai Pharmaceuticals, which is starting a trial to test the safety of a new anti-tumor ... FierceBiotech YM BIOSCIENCES REPORTS FISCAL FIRST QUARTER 2010 OPERATIONAL AND FINANCIAL RESULTS - Nov 11, 2009 Nimotuzumab's anti-tumor activity has led to its approval for marketing in 23 countries. In more than 5000 patients reported as having been treated with ... Trading Markets (press release) ACR: No Increase in Infections with Anti-TNF Therapy - Oct 22, 2009 PHILADELPHIA -- Two new studies failed to find a solid link between anti-tumor necrosis factor (anti-TNF) therapy and infections among rheumatoid arthritis ... MedPage Today Chelsea Therapeutics Reports Third Quarter 2009 Results - Nov 2, 2009 Chelsea is also developing a portfolio of metabolically inert oral antifolate molecules engineered to have potent anti-inflammatory and anti-tumor ... Reuters Early Treatment Needed for Drug-Induced Hypertension Management of cediranib ... - Nov 12, 2009 Anti-tumor activity was observed with no apparent effect of cediranib dose or antihypertensive prophylaxis, with nine partial responses and 38 patients with ... ModernMedicine ImmunoGen, Inc. Announces Presentations at the AACR-NCI-EORTC International ... - Nov 10, 2009 ..."Potent antigen-specific anti-tumor activity observed with antibody-drug conjugates (ADCs) made using a new class of DNA-crosslinking agentsâ€? (abstract ... WELT ONLINE Infinity Reports Recent R&D Highlights and Third Quarter 2009 Results - Nov 9, 2009 Infinity has previously presented data demonstrating significant anti-tumor activity of IPI-926 in a number of preclinical studies, including in models of ... CNNMoney.com (press release) Chelsea Therapeutics Presents Novel, Metabolically Inert Autoimmune Portfolio ... - Oct 20, 2009 Chelsea's novel, orally available and metabolically inert antifolate compounds are engineered to have potent autoimmune, anti-inflammatory and anti-tumor ... Reuters YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN ... - Oct 29, 2009 Nimotuzumab's anti-tumor activity has led to its approval for marketing in 23 countries. In more than 5000 patients reported as having been treated with ... Reuters Beyond the Abstract - Fibrin clot inhibitor medication and efficacy of ... - Oct 29, 2009 For example, the impact of the anti-inflammatory properties of aspirin-like agents on BCG anti-tumor activity, which is in part immune-based, remains to be ... UroToday Targeting EGFR with photodynamic therapy in combination with Erbitux enhances ... - Nov 2, 2009 The aim of this study was to investigate the anti-tumor effects of PDT plus Erbitux, an angiogenesis inhibitor that targets epidermal growth factor receptor ... 7thSpace Interactive (press release) MDRNA To Present Data On Tumor Reduction At Cancer Therapy Conference - Oct 29, 2009 ..."Development of Novel RNAi-based Therapeutics Targeting Survivin for Treatment of Liver and Bladder Cancer," presented by Dr. Seth, describes anti-tumor ... Medical News Today (press release) Entest BioMedical, Inc. Discusses How Therapies in Development May Yield ... - Nov 10, 2009 ...perfecting the use of cell lines for sustained release of immunologically relevant cytokines for maximum anti-tumor immune responses in treating cancer. ... PR Web (press release) MorphoSys wins German approval to initiate Phase Ib/IIa arthritis trial - Nov 10, 2009 ...disease-modifying antirheumatic drugs and/or anti-tumor necrosis factor -alpha will each receive four infusions of either the HuCAL-derived antibody ... Therapeutics Daily (press release) (registration) www.StockMarketingInc.com: Our Members Profit!! Undt!! Sign Up For Our ... - Oct 20, 2009 Chelsea's novel, orally available and metabolically inert antifolate compounds are engineered to have potent autoimmune, anti-inflammatory and anti-tumor ... Trading Markets (press release) NeoPharm, Inc. Announces Third Quarter 2009 Financial Results and Clinical ... - Oct 26, 2009 ...the active ingredient of Taxol, designed to evaluate the anti-tumor effect and safety/tolerability of LEP-ETU in metastatic breast cancer. ... Reuters FDA Clears SQI Diagnostics' Array-Based RA Test for Sale in US - Nov 3, 2009 ...inflammatory bowel disease, vasculitis, and a research-use-only screen for determining the amount of anti-tumor necrosis factor agents in serum. ... GenomeWeb Daily News GenVec, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile ... - Nov 13, 2009 Using GenVec's core adenovector technology, TNFerade stimulates the production of tumor necrosis factor alpha (TNFa), a known anti-tumor protein, ... PR-inside.com (press release) The mannosylated extracellular domain of Her2/neu produced in P. pastoris ... - Oct 30, 2009 ...produced in yeast P. pastoris, which confers mannosylation of the protein, to act as a potent anti-tumor vaccine against Her2/neu overexpressing tumors. ... 7thSpace Interactive (press release) Mesothelioma program at University of Texas cancer center sees 150 new ... - Oct 25, 2009 One of the treatment agents being studied is Sprycel (dasatanib), which has shown an anti-tumor effect in participants after just four weeks of therapy. ... Mesothelioma News Chelsea Therapeutics to Present at the Oppenheimer 20th Annual Healthcare ... - Oct 27, 2009 Chelsea is also developing a portfolio of metabolically inert oral antifolate molecules engineered to have potent anti-inflammatory and anti-tumor ... Reuters Something fishy about omega 3 and flax - Nov 8, 2009 Besides anti-tumor properties, lignins also seem to have antibacterial, antifungal, and antiviral properties. Add to this some German research that flax and ... Truth In Aging (blog) Revolutionary New Treatment for Sciatica Advances in the Clinic - Oct 27, 2009 Kato, K., et al., Immediate anti-tumor necrosis factor-alpha (etanercept) therapy enhances axonal regeneration after sciatic nerve crush. ... PR Web (press release) Media Advisory – YM Biosciences to Present at the Merriman Curhan Ford 6th ... - Nov 3, 2009 Nimotuzumab's anti-tumor activity has led to its approval for marketing in 23 countries. In more than 5000 patients reported as having been treated with ... PharmaLive.com (press release) Polyarticular JIA: The Elusive Quest for Disease Remission - Nov 2, 2009 Seventy-two percent of patients were treated with methotrexate and 11.5% with an anti-tumor necrosis factor (TNF) medication such as etanercept, infliximab, ... AAP Grand Rounds (registration) EMEA Awards Orphan Drug Designation to ARQ 197 for Treatment of Soft Tissue ... - Oct 20, 2009 Pre-clinical data have demonstrated that ARQ 197 inhibits c-MET activation in a wide range of human tumor cell lines and shows anti-tumor activity against ... Trading Markets (press release) Additional PML Brain Infection Cases Linked to Tysabri and Rituxan - Oct 26, 2009 She is the third arthritis patient to contract PML on Rituxan, but the first patient to contract the brain infection who was not also receiving anti-tumor ... AboutLawsuits.com MOLOGEN reaches primary end points in MGN1703 study - Nov 4, 2009 Secondary end points were evaluation of the pharmacokinetics and pharmacodynamics of MGN1703 as well as of the provisional anti-tumor effect of MGN1703 ... PipelineReview.com (press release) Anti-tumor drug extends lung cancer patients' lives - Mar 14, 2005 By Liz Szabo, USA TODAY. Avastin, a cancer therapy approved a year ago to treat colon tumors, also helps prolong life in lung cancer patients, the National ... USA Today US researchers identify new anti-tumor gene_English_Xinhua - Dec 17, 2008 WASHINGTON, Dec. 16 (Xinhua) -- Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with ... æ–°å?Žç½‘ Oxigene reports positive results for anti-tumor drug - Oct 5, 2007 Oct 5 (Reuters) - Oxigene Inc (OXGN.O) said, in an ongoing Phase Ib study, its anti-tumor drug candidate administered to patients with advanced solid tumors ... Reuters Nektar product shows 'significant anti-tumor activity' in Phase I... - May 16, 2008 NEW YORK (Thomson Financial) - Nektar Therapeutics Friday said the Phase I trial for its NKTR-102 product showed 'significant' anti-tumor activity in ... Forbes Potential for stimulating host anti-tumor immune response via RNAi- … - Mar 16, 2007 1 Department of Chemistry and Biochemistry Norfolk Virginia, Old Dominion University, Hampton, VA, USA. E-mail: nklai001@odu.edu ... Nature.com Dying T lymphocytes call for the death of tumor cells - Aug 17, 2006 Immunotherapy that specifically targets tumor cells is the preferred approach to induce tumor regression. Over the past decade, significant progress has ... Nature.com Turning an Anti-Tumor Gene Back On Could Fight Cancer - Jun 15, 2007 FRIDAY, June 15 (HealthDay News) -- Cancer drugs may be able to switch on a gene that tumor cells have switched off, potentially offering a new target for ... Washington Post What Are Anti-Tumor Necrosis Factor (Anti-TNF) Medications And How … - Jan 3, 2008 Question: What are anti-tumor necrosis factor (anti-TNF) medications and how are they used to treat rheumatoid arthritis? ... ABC News Turning an Anti-Tumor Gene Back On Could Fight Cancer - Jun 11, 2007 By Robert Preidt. FRIDAY, June 15 (HealthDay News) -- Cancer drugs may be able to switch on a gene that tumor cells have switched off, potentially offering ... ABC News … (HVJ-E) Solely Induces Specific Anti-Tumor Immune Response and … - Jul 1, 2005 Inactivated Sendai virus particle (Hemagglutinating virus of Japan envelope, HVJ-E) has been developed as a safe and efficient non- viral vector for gene ... Nature.com … and treatment in a patient receiving anti-tumor necrosis factor... - Dec 29, 2006 Background A 54-year-old man with a 22-year history of rheumatoid arthritis and an 8-year history of chronic obstructive pulmonary disease presented with ... Nature.com NICE guidelines on anti-tumor necrosis factor therapy for RA - Sep 4, 2008 The UK National Institute for Health and Clinical Excellence (NICE) utilizes the available evidence to provide guidance on the efficacy and ... Nature.com … IMPROVED CANCER DRUGS ANTI-TUMOR AGENTS WOULD BE LESS … - Jul 6, 2006 University of Minnesota biochemists are seeking a "new generation" of cancer drugs that slows the growth of tumors at much less cost than existing versions. ... $2.95 - St. Paul Pioneer Press - NewsBank 1005. Replication and Anti-Tumor Efficacy of Conditionally Replicating... - Nov 25, 2005 In order to improve the efficacy of first generation adenoviral vectors for glioma treatment, we designed conditionally replicating adenoviruses (CRAd's) in ... Nature.com RADIATE: more treatment options for patients with an inadequate … - Oct 15, 2008 Tocilizumab is a safe and effective therapy for patients with rheumatoid arthritis who have failed to respond to previous treatment with tumor necrosis ... Nature.com … of Clinical Oncology Publishes Significant Anti-Tumor Activity of... - Mar 2, 2005 TUSTIN, Calif., March 2 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. announced today the publication of data in the Journal of Clinical ... RedOrbit Pfizer says drug shows promise vs pancreatic cancer - Jun 4, 2007 By Ransdell Pierson and Bill Berkrot. NEW YORK, June 4 (Reuters) - Pfizer Inc. (PFE.N) said on Monday its experimental drug axitinib showed enough promise ... Reuters Kosan Presents Clinical Data Showing Anti-Tumor Activity of KOS-862 … - Jun 6, 2006 On the 5 June 2006, Kosan Biosciences Incorporated reported encouraging interim clinical data on KOS-862 and KOS-1584, the company's most advanced ... Lifescience-online … Preclinical Data Demonstrating Anti-Tumor Activity of Talabostat - Apr 17, 2005 Point Therapeutics, Inc. (NASDAQ: POTP) today presented preclinical data on its lead product candidate talabostat, demonstrating tumor growth suppression of ... RedOrbit Is anti-tumor necrosis factor therapy effective in reducing uveitis... - Mar 15, 2007 Guignard S et al. (2006) Efficacy of tumour necrosis factor blockers in reducing uveitis flares in patients with spondylarthropathy: a retrospective study. ... Nature.com … Doxorubicin And Zoledronic Acid Have Powerful Anti-Tumor Effect In... - Aug 15, 2008 ScienceDaily (Aug. 15, 2008) — The use of doxorubicin followed by zoledronic acid reduced tumor size substantially in a mouse model of breast cancer that ... sciencedaily.com Adherex Initiates Clinical Trial Program for ADH-1 in Combination... - Oct 3, 2006 Adherex Technologies Inc. (TSX: AHX)(AMEX: ADH), a biopharmaceutical company with a broad portfolio of oncology products under development, today announced ... CNNMoney.com Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102... - Oct 24, 2008 GENEVA and SAN CARLOS, Calif. , Oct. 24 /PRNewswire-FirstCall/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported positive Phase 1 data for its lead ... Genetic Engineering News - Genetic Engineering News (press release) A novel mechanism of action for anti-tumor agent, CA4P - Oct 8, 2005 Anti-angiogenic agents have been successful in the clinic for blocking the growth of solid tumors. However, these agents used in combination with ... Medical News Today - Medical News Today (press release) The genome and transcriptomes of the anti-tumor agent Clostridium... - Nov 19, 2006 1 The Howard Hughes Medical Institute, The Ludwig Center for Cancer Genetics & Therapeutics at The Sidney Kimmel Comprehensive Cancer Center, and Department ... Nature.com … Announces Preclinical Data Demonstrating Anti-Tumor Activity With... - Oct 24, 2007 SAN FRANCISCO, Oct. 24 /PRNewswire/ -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing novel cancer therapies, today announced ... Free with registration - PR Newswire - AccessMyLibrary.com … in Cancer Research Demonstrates Anti-Tumor Activity of Micromet's... - Jan 22, 2008 BETHESDA, Md., Jan. 22 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of ... Free with registration - PR Newswire - AccessMyLibrary.com The genome and transcriptomes of the anti-tumor agent Clostridium... - Nov 19, 2006 Each column represents a different microarray experiment performed with RNA from spores or vegetative bacteria growing at early-, mid-, or late-log phase. ... Nature.com EntreMed says anti-tumor drug shows promise - Oct 12, 2005 For the second time this week, money-losing EntreMed has said one of its experimental drugs shows promise. The Rockville-based company Wednesday said a ... Washington Business Journal SFDA bans anti-tumor drug due to side effects. - Jul 9, 2007 Shanghai. July 9. INTERFAX-CHINA - China's State Food and Drug Administration announced Saturday it has banned a drug produced by Shanghai Hualian ... $4.95 - China Business News - ECNext Novel Anti-tumor Vaccine Developed - Oct 3, 2008 ScienceDaily (Oct. 3, 2008) — A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National ... sciencedaily.com eGene's DNA Analyzer Used for Anti-Tumor Medication-Related Large- … - Apr 25, 2006 ...eGene Inc. (OTCBB:EGEI), developers of a revolutionary high-performance genetic analysis technology, announced today that its analyzer was used in ... RedOrbit … Lead Compound CA4P Enhances the Anti-Tumor Activity of Avastin in ... - Feb 14, 2005 Waltham, MA, Feb. 14,2005 -- OXiGENE, Inc. (Nasdaq: OXGN, XSSE: OXGN) announced today that Dietmar Siemann, Ph.D., chairman of its scientific advisory board ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic... - Feb 15, 2007 GRN163L has been demonstrated to have anti-tumor effects in a wide range of hematological and solid tumor models and appears to be unique in its observed ... Free with registration - Business Wire - AccessMyLibrary.com Down syndrome's anti-tumor effect.(GENETICS)(Brief article) | Article... - Jan 12, 2008 Down syndrome's anti-tumor effect.(GENETICS)(Brief article) ... find Science News articles. People with Down syndrome face a heightened risk of developing ... Pay-Per-View - Science News - HighBeam Research Kosan Presents Clinical Data Showing Anti-Tumor Activity of KOS-862 … - Jun 5, 2006 HAYWARD, Calif., June 5 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated reported encouraging interim clinical data on KOS-862 and KOS-1584, ... Free with registration - PR Newswire - AccessMyLibrary.com NKTR-102 Demonstrates Anti-Tumor Activity And Improved … - Sep 28, 2007 Nektar Therapeuticsannounced positive new preclinical data regarding its proprietary product candidate, NKTR-102 (PEG-irinotecan), which is under ... emaxhealth.com 279. Eradication of Renal Cell Carcinoma in Mice Mediated by NK Cell ... - Jul 1, 2005 Conventional chemotherapy and radiation therapy have shown little antitumour activity against renal cell carcinoma (RCC). Although interleikin-2 or ... Nature.com Patient's own infection-fighting T cells put late-stage melanoma into... - Jun 18, 2008 SEATTLE Researchers describe the first successful use of a human patient's cloned infection-fighting T cells as the sole therapy to put an advanced ... Genetic Engineering News - Genetic Engineering News (press release) Compound Shows Anti-Tumor Activity - Apr 4, 2006 Results from preclinical studies show that the anti-cancer compound AV-412 -- a EGFR/HER2 kinase inhibitor -- demonstrated anti-tumor activity against ... HealthCentral.com Probing proteins can lead to better understanding of anti-tumor agents - Jan 29, 2007 There are a number of naturally occurring chemicals that are used in phototherapy of skin diseases. Hypocrellin A (HA), which can be extracted from a ... News-Medical.net Targeting epitopes in prostate-specific membrane antigen for antibody... - May 10, 2005 Correspondence: GP Haas, Department of Urology, SUNY Upstate Medical University, 750 East Adams Street, Syracuse, NY 13210, USA. E-mail: haasg@upstate.edu ... Nature.com Zoledronic acid may have anti-tumor effect with neoadjuvant … - Dec 12, 2008 SAN ANTONIO — Researchers in Sheffield and Leeds in the United Kingdom found that women with advanced hormone-receptor–positive breast cancer assigned to ... HemOncToday New Data Demonstrates Talabostat's Anti-Tumor and Anti-Metastatic … - Oct 30, 2006 Point Therapeutics, Inc. (NASDAQ: POTP) presented new data in an osteosarcoma model demonstrating that mice treated with talabostat had a four- fold ... Genetic Engineering News - Genetic Engineering News (press release) Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant Preclinical … - Jan 7, 2005 BRIDGEWATER, NJ--(BUSINESS WIRE)--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced new preclinical data showing that treatment with PEG-SN38, ... businesswire.com … Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer... - Apr 17, 2007 SAN DIEGO, April 17 /PRNewswire-FirstCall/ -- Anadys Pharmaceuticals, Inc. presented data from an in vitro study showing that the active metabolite of ... Free with registration - PR Newswire - AccessMyLibrary.com SciClone asks China for liver-cancer treatment OK - Dec 28, 2006 SciClone Pharmaceuticals Inc. said Thursday it has asked the Chinese State Food and Drug Administration to approve its new product for the treatment of ... Bizjournals.com CEL-SCI Enters Agreement With National Institutes of Health - Oct 7, 2008 CEL-SCI Enters Agreement With National Institutes of Health Clinical Center To Determine the Molecular Basis of Multikine Anti-Tumor Effect PR Newswire ... Bloomberg New Clues To The Dark Side Of A Key Anti-tumor Guardian - Nov 22, 2005 ScienceDaily (Nov. 22, 2005) — The p53 protein is known to be a critical player in our body's natural defense against cancer -- it is absent in many types ... sciencedaily.com Introgen's vaccine works in lung cancer - Jun 4, 2007 CHICAGO, June 4 (UPI) -- US firm Introgen said Monday its potential cancer vaccine INGN 225 shows promise for patients with small-cell lung cancer. ... United Press International Children's National researchers develop novel anti-tumor vaccine - Oct 2, 2008 WASHINGTON, DC—A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in ... eurekalert.org Phenoxodiol Delays Tumor Progression in Late-Stage Hormone … - Nov 17, 2005 PHILADELPHIA, Nov. 17 /PRNewswire-FirstCall/ -- A new study presented today at the International Conference on Molecular Targets and Cancer Therapeutics in ... Free with registration - PR Newswire - AccessMyLibrary.com CytImmune's CYT-6091 Anti-Tumor Nanotherapeutic to Begin Testing in a... - May 31, 2006 ROCKVILLE, Md., May 31 /US Newswire/ -- CytImmune Sciences Inc., an early clinical stage nano-medicine company focused on the development and targeted ... Free with registration - America's Intelligence Wire - AccessMyLibrary.com Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant Preclinical … - Apr 17, 2007 BRIDGEWATER, NJ -- Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced new preclinical data showing that treatment with PEG-SN38, Enzon's PEGylated ... Free with registration - Business Wire - AccessMyLibrary.com … Data Demonstrating Superior Anti-Tumor Immunity for Multiantigen … - Apr 14, 2008 Cell Genesys, Inc. (Nasdaq:CEGE) announced today data from a preclinical study demonstrating that multiantigen immunotherapies provide superior anti-tumor ... Genetic Engineering News - Genetic Engineering News (press release) OXiGENE's CA4P Demonstrates Anti-tumor Activity in Preclinical … - Feb 4, 2005 WALTHAM, Mass. -- OXiGENE, Inc. (NASDAQ: OXGN, XSSE: OXGN) announced today the publication of a preclinical study using local administration of ... Free with registration - Business Wire - AccessMyLibrary.com Alfacell Says Onconase Shows Anti-Tumor Activity - Nov 17, 2006 Alfacell Corporation has presented preclinical findings that support the potential anti-tumor activity of Onconase in non-small-cell lung cancer. ... RedOrbit New Positive Data Announced for NKTR-102 (PEG-Irinotecan), Highlights... - Jun 2, 2008 SAN CARLOS, Calif., June 2 /PRNewswire-FirstCall/ -- Nektar Therapeutics announced new positive data today from a Phase 1 clinical study for NKTR-102 ... RedOrbit … Phase 2 Data for Exelixis' XL880 Show Anti-Tumor Activity in... - Oct 24, 2007 SAN FRANCISCO, Oct. 24 /PRNewswire-FirstCall/ -- Exelixis, Inc. today reported encouraging data from an ongoing phase 2 trial of XL880, an inhibitor of MET ... $4.95 - PR Newswire - ECNext Why Does Gecko, A Chinese Traditional Medicine, Have Anti-tumor … - Sep 29, 2008 ScienceDaily (Sep. 29, 2008) — Gecko is a Chinese traditional medicine. It has definite effect on malignant tumor, especially on digestive system tumor. ... sciencedaily.com Press Release: Significant Anti-Tumor Activity of NKTR-102 in... - May 16, 2008 Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … : Positive Preclinical Data Demonstrating Anti-Tumor Activity of... - Oct 23, 2008 Positive Preclinical Data Demonstrating Anti-Tumor Activity of NKTR-105 (PEG-docetaxel) Presented at 20th EORTC-NCI-AACR Conference. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Tumor immunotherapy across MHC barriers using allogeneic T-cell … - Mar 30, 2008 We present a strategy for adoptive immunotherapy using T-lineage committed lymphoid precursor cells generated by Notch1-based culture. ... Nature.com Skin flaps deliver cancer-fighting therapy, ASPS study reveals - May 9, 2008 ARLINGTON HEIGHTS, Ill: Using gene therapy, plastic surgeons have delivered cancer fighting proteins through skin flaps placed on cancerous tumors on rats ... The Hindu … Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity... - Apr 17, 2007 PRINCETON, NJ, April 17 /PRNewswire-FirstCall/ -- Medarex, Inc. today presented preclinical data demonstrating potent anti- tumor activity from two separate ... Free with registration - PR Newswire - AccessMyLibrary.com Radiation Boosts Anti-Tumor Action of Bavituximab - Sep 18, 2007 By David Douglas. NEW YORK SEPT 18, 2007 (Reuters Health) - Work in mice with human lung cancer xenografts shows that radiation augments the curative action ... Cancerpage.com Anti-Tumor Effects Demonstrated With Enriched Tumor Antigen Specific ... - Feb 21, 2006 By Alan McClelland. HONOLULU, HI -- February 21, 2006 -- Researchers reported progress in the development of targeted immunotherapy for Epstein Barr virus ... DG News CoQ10 shows promising anti-tumor activity.(News) - Jul 1, 2005 Results from in vitro and preclinical in vivo studies suggest that topically applied coenzyme Q10 (CoQ10) has exciting potential as a safe and effective ... Free with registration - Dermatology Times - AccessMyLibrary.com Researchers Identify New Anti-Tumor Gene - Dec 23, 2008 Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that ... FierceBiotech New Study Reports Preclinical Findings Involving Celsion Heat... - Jan 3, 2007 COLUMBIA, Md. -- CELSION CORPORATION (AMEX:CLN) today reported that in an article published in the Journal of the National Cancer Institute, on January 3, ... Free with registration - Business Wire - AccessMyLibrary.com Researchers identify new anti-tumor gene - Dec 16, 2008 RICHMOND, Va. (Dec. 16, 2008) Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and ... Genetic Engineering News - Genetic Engineering News (press release) … Pharma Announces-Discovery of Novel Anti-tumor Antimitotic Agents... - Jul 25, 2007 Scientists at Duquesne University and the Medical University of South Carolina report in the on line version of the Journal of Medicinal Chemistry (50,3290 ... Genetic Engineering News - Genetic Engineering News (press release) In- Depth Research on Peregrine Pharmaceuticals Inc. - Apr 17, 2007 Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of ... Free with registration - M2 Presswire - AccessMyLibrary.com Anti-tumor therapy with endoscopic ultrasound may fight cancer more … - Sep 12, 2008 The chairman of EUS2008 today announced that investigational research on a therapeutic technique that will allow physicians to directly inject malignant ... Eureka! Science News Serotherapy with thymoglobulin and alemtuzumab differentially … - Nov 5, 2007 Correspondence: Dr O Penack, Department of Immunology and Medicine, Memorial Sloan-Kettering Cancer Center, Zuckerman Building, 14th Floor, Room Z-1419, ... Nature.com Effect of Anti-Tumor Necrosis Factor- Gene Therapy on Wear Debris- … - Jul 1, 2008 Lisa M. Childs, MS, J. Jeffrey Goater, MS, Regis J. O'Keefe, MD, PhD and Edward M. Schwarz, PhD. Department of Microbiology and Immunology, University of ... Journal of Bone and Joint Surgery - Journal of Bone and Joint Surgery... New clues to the dark side of a key anti-tumor guardian - Nov 18, 2005 The p53 protein is known to be a critical player in our body's natural defense against cancer--it is absent in many types of tumor cells--but it also ... PsychCentral.com New clues to the dark side of a key anti-tumor guardian - Dec 1, 2005 The p53 protein is known to be a critical player in our body's natural defense against cancer--it is absent in many types of tumor cells--but it also ... Anti Aging News … ' Novel Monoclonal Antibody Shows Potent Anti-tumor Activity... - Oct 5, 2006 ROCKVILLE, Md., Oct. 5 /PRNewswire/ -- MacroGenics, Inc. today announced the publication of data showing that the company's humanized monoclonal antibody ... Free with registration - PR Newswire - AccessMyLibrary.com Anti-Tumor Activity and Pharmacokinetic Properties of NKTR-102 (PEG- … - Jul 26, 2007 SAN CARLOS, Calif., July 26 /PRNewswire-FirstCall/ -- The first peer- reviewed presentations of preclinical data for Nektar Therapeutics' proprietary ... Free with registration - PR Newswire - AccessMyLibrary.com … -Irinotecan) Demonstrates Significant Anti-Tumor Activity and... - Sep 27, 2007 NKTR-102 (PEG-Irinotecan) Demonstrates Significant Anti-Tumor Activity and Improved Pharmacokinetic Profile in Preclinical Studies Presented at ECCO. from ... Pay-Per-View - PR Newswire - HighBeam Research A novel mechanism of action for anti-tumor agent, CA4P - Sep 29, 2005 Anti-angiogenic agents have been successful in the clinic for blocking the growth of solid tumors. However, these agents used in combination with ... PsychCentral.com Severe uveitis in an HLA-B27-positive patient with ankylosing... - Dec 19, 2005 Background A 36-year-old male presented with bilateral, anterior, chronic uveitis, with cystoid macular edema. Decimal visual acuity was 0.25 in the right ... Nature.com … ' Lead Compound DAVANAT Enhances Anti-Tumor Activity of Avastin/5- … - Mar 22, 2005 NEWTON, Mass. -- Pro-Pharmaceuticals, Inc. (Amex: PRW), a developer of novel carbohydrate compounds that enable the targeted delivery of chemotherapy drugs ... $4.95 - Business Wire - ECNext BioE, U of Texas partner on stem-cell therapy - Jan 29, 2007 BioE Inc., a biomedical startup company that has made headlines for its work in deriving stem cells from human umbilical cord blood, announced its ... Bizjournals.com … ; IL-12-secreting dendritic cells generate anti-tumor immunity in... - Mar 22, 2005 According to recent research published in the journal Cancer Immunology Immunotherapy, "To induce cytolytic immunity, dendritic cells (DCs) need to release ... Pay-Per-View - Cancer Weekly - Factiva, from Dow Jones Insert Therapeutics Describes In Vivo Performance and Versatility of... - Apr 20, 2005 Insert Therapeutics, Inc. Chief Scientific Officer, Thomas Schluep, Sc.D., presented data today demonstrating the improved biodistribution and preclinical ... RedOrbit New anti-tumor compound in a phase I clinical trial in people with... - Jan 21, 2008 Researchers at Emory University have developed a novel anti-tumor compound that represents a distinct strategy: targeting one of the most important ... TopCancerNews.com New Preliminary Phase II Data Show Anti-Tumor Activity of Single... - Sep 26, 2007 Preliminary results from a new Phase II study provide data on the anti-tumor activity and tolerability of sunitinib malate in patients with advanced gastric ... Genetic Engineering News - Genetic Engineering News (press release) Cancer Therapy; Anti-tumor cytotoxicity mediated by CD8+ or CD4-CD8- ... - Aug 29, 2006 Keywords: Boston, Massachusetts, United States, Anti Tumor Effects, Anticancer Therapy, Bone Marrow Transplantation, Cytotoxic T Lymphocyte, Cytotoxicity, ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Clinical Data Published in 'Science' Show Tumor Regressions in … - Aug 14, 2008 BETHESDA, Md., Aug. 14 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of ... RedOrbit CancerVax: Anti-Tumor Drug Study in '06 - Apr 3, 2006 CancerVax said Monday it has been OK'd to start clinical trials of its drug candidate D93 for solid tumors later in the year. ... RedOrbit … ; IL-12-secreting dendritic cells generate anti-tumor immunity in... - Mar 23, 2005 According to recent research published in the journal Cancer Immunology Immunotherapy, "To induce cytolytic immunity, dendritic cells (DCs) need to release ... Pay-Per-View - Vaccine Weekly - Factiva, from Dow Jones Press Release: Significant Anti-Tumor Activity and Extended Half-Life... - Oct 24, 2008 Significant Anti-Tumor Activity and Extended Half-Life of NKTR-102 (PEG-irinotecan) Highlighted in Phase 1 Data Presented at EORTC-NCI-AACR Symposium. from ... Pay-Per-View - PR Newswire - HighBeam Research Anti-tumor TCM price cuts save RMB 1.3 million - Nov 17, 2006 Shanghai. November 17. INTERFAX-CHINA - China's latest price cuts on 32 anti-tumor Traditional Chinese Medicines can save consumers about RMB 1.3 billion ... Free with registration - China Business News - AccessMyLibrary.com Shikonin Derivative Has Potent Anti-Tumor Activity in Vivo and in... - Sep 15, 2006 NEW YORK SEP 15, 2006 (Reuters Health) - SH-7, a derivative of shikonin, has potent anti-tumor effects against a broad variety of cell lines, ... Cancerpage.com Pieris Demonstrates Potent Anti-Tumor Activity of a VEGF-Specific … - Mar 29, 2007 FREISING-WEIHENSTEPHAN, Germany, March 29 /PRNewswire/ -- Pieris AG, a bio-pharmaceutical company developing therapeutic products comprising of ... Free with registration - PR Newswire - AccessMyLibrary.com … of Clinical Oncology Publishes Significant Anti-Tumor Activity of... - Mar 2, 2005 Journal of Clinical Oncology Publishes Significant Anti-Tumor Activity of Tumor Necrosis Therapy for Treating Patients With Advanced Lung Cancer. from PR ... Pay-Per-View - PR Newswire - HighBeam Research Anti-Tumor Activity And Pharmacokinetic Properties Of NKTR-102 (PEG- … - Jul 27, 2007 The first peer- reviewed presentations of preclinical data for Nektar Therapeutics' (Nasdaq: NKTR) proprietary product, NKTR-102 (PEG-irinotecan) is ... Medical News Today - Medical News Today (press release) … ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic … - Dec 10, 2008 SOMERSET, NJ , Dec. 10 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL) today announced that American Society of Hematology (ASH) annual ... RedOrbit |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |